Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Japan Pharmaceutical Market Report by Prescription Type (Prescription Drugs, OTC Drugs), Therapeutic Category (Antiallergics, Blood and Blood Forming Organs, Cardiovascular System, Dermatological, Genito Urinary System, Respiratory System, Sensory Organs, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A18674
Year End
sale
Buy Now
Market Overview:
Japan pharmaceutical market size reached USD 80.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 101.9 Billion by 2032, exhibiting a growth rate (CAGR) of 2.71% during 2024-2032. Numerous treatments and innovative therapies and the increasing investments in the R&D activities for developing medicines, are primarily augmenting the market growth.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023 |
|
Forecast Years
|
2024-2032 |
|
Historical Years
|
2018-2023
|
| Market Size in 2023 | USD 80.1 Billion |
| Market Forecast in 2032 | USD 101.9 Billion |
| Market Growth Rate (2024-2032) | 2.71% |
The pharmaceutical industry represents a confluence of science, innovation, and therapeutic care, dedicated to advancing global health. At its core, this sector is responsible for the research, development, production, and distribution of medications designed to prevent, manage, or cure a plethora of medical conditions and diseases. Spanning from life-saving vaccines to everyday pain relievers, pharmaceuticals play an integral role in enhancing the quality of life and increasing life expectancy. The journey of drug development is a complex and rigorous process, necessitating extensive research, clinical trials, and regulatory approvals to ensure both efficacy and safety for patients. Beyond the tangible medications, the pharmaceutical industry's value also lies in its relentless pursuit of new therapeutic frontiers, breakthrough treatments, and innovations that have the potential to redefine medical paradigms. As health challenges continue to evolve, the importance of this industry, underpinned by its commitment to bettering human health, remains paramount.
Japan Pharmaceutical Market Trends:
Growing investments in biopharmaceuticals and precision medicine
Growing investments in biopharmaceuticals and precision medicines is rapidly transforming the dynamics of the pharmaceutical industry in Japan. Biopharmaceuticals, such as biologics, and biosimilars are gaining more preference due to originality in treatment of chronic diseases, such as cancer or autoimmune diseases. With advancements in genomics and personalized medicine, the focus is shifting towards treatments tailored to individual genetic profiles. As a result, major Japanese drug manufacturers are engaging in joint ventures involving overseas companies and research centers to foster this technology. An enhanced focus on individualized treatments is further extending the range of the pharmaceutical market by offering targeted solutions to previously hard-to-solve diseases.
Aging Population and Rising Healthcare Demand
The rapidly aging population is a key factor propelling growth in the pharmaceutical market. This demographic shift is increasing the overall demand for medications targeting age-related diseases and chronic conditions such as cardiovascular diseases, diabetes, and Alzheimer's. Also, with shifting focus to managing chronic illnesses and improving the quality of life for senior citizens, the demand for effective treatments and medications is growing with the improving healthcare system. Furthermore, pharmaceutical companies are expanding their R&D efforts in geriatric medicines, developing comprehensive drug formulations specifically designed for elderly care. This demographic trend is attracting heavy investments from both local and international firms, contributing to the Japan pharmaceutical market share.
Continual technological advancements in drug development and manufacturing
Ongoing innovations in cutting-edge advancements, such as artificial intelligence (AI), machine learning (ML), and process automation, particularly as they are integrated into both preclinical research and drug manufacturing, are supporting the growth of the market. Data-driven methods in clinical trials and drug safety monitoring are helping pharmaceutical companies bring new therapies to market faster. Wearable devices and digital health tools, including telemedicine are also fostering better drug adherence and more personalized treatment plans. Additionally, innovations in bioprocessing and the use of robotics in pharmaceutical production are improving efficiency, while advanced analytics support better decision-making throughout the drug development lifecycle.
Japan Pharmaceutical Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on prescription type and therapeutic category.
Prescription Type Insights:
- Prescription Drugs
- Branded
- Generics
- OTC Drugs
The report has provided a detailed breakup and analysis of the market based on the prescription type. This includes prescription drugs (branded and generics) and OTC drugs.
Therapeutic Category Insights:
- Antiallergics
- Blood and Blood Forming Organs
- Cardiovascular System
- Dermatological
- Genito Urinary System
- Respiratory System
- Sensory Organs
- Others
A detailed breakup and analysis of the market based on the therapeutic category have also been provided in the report. This includes antiallergics, blood and blood forming organs, cardiovascular system, dermatological, genito urinary system, respiratory system, sensory organs, and others.
Regional Insights:
- Kanto Region
- Kansai/Kinki Region
- Central/ Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Japan Pharmaceutical Market News:
- On 1st October 2024, Nxera Pharma Co., Ltd. formed a partnership agreement with Shionogi & Co., Ltd. regarding the distribution and sales for QUVIVIQ™ (daridorexant 25 and 50 mg) in Japan. QUVIVIQ is a novel dual orexin receptor antagonist, discovered by Idorsia Pharmaceuticals Ltd, that was approved by the ministry of health, labour, and welfare of Japan (“MHLW”) for the treatment of adult patients with insomnia.
Japan Pharmaceutical Market Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | Billion USD |
| Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
| Prescription Types Covered |
|
| Therapeutic Categories Covered | Antiallergics, Blood and Blood Forming Organs, Cardiovascular System, Dermatological, Genito Urinary System, Respiratory System, Sensory Organs, Others |
| Regions Covered | Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the Japan pharmaceutical market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan pharmaceutical market?
- What is the breakup of the Japan pharmaceutical market on the basis of prescription type?
- What is the breakup of the Japan pharmaceutical market on the basis of therapeutic category?
- What are the various stages in the value chain of the Japan pharmaceutical market?
- What are the key driving factors and challenges in the Japan pharmaceutical?
- What is the structure of the Japan pharmaceutical market and who are the key players?
- What is the degree of competition in the Japan pharmaceutical market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan pharmaceutical market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the Japan pharmaceutical market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan pharmaceutical industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More